摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(6-(1-hydroxy-3-methylbutan-2-ylamino)imidazo[1,2-b]pyridazin-3-yl)-2-methoxyphenol | 1012343-81-5

中文名称
——
中文别名
——
英文名称
4-(6-(1-hydroxy-3-methylbutan-2-ylamino)imidazo[1,2-b]pyridazin-3-yl)-2-methoxyphenol
英文别名
4-[6-[(1-hydroxy-3-methylbutan-2-yl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methoxyphenol
4-(6-(1-hydroxy-3-methylbutan-2-ylamino)imidazo[1,2-b]pyridazin-3-yl)-2-methoxyphenol化学式
CAS
1012343-81-5
化学式
C18H22N4O3
mdl
——
分子量
342.398
InChiKey
ZYMOFWHXOIPXLE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    25
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    91.9
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE
    申请人:Durand-Reville Thomas
    公开号:US20110021513A1
    公开(公告)日:2011-01-27
    The present invention relates to modulators of IRAK kinase and provides compositions comprising such modulators, as well as methods therewith for treating conditions or diseases mediated by or associated with IRAK kinase.
    本发明涉及IRAK激酶的调节剂,并提供包含这些调节剂的组合物,以及利用这些调节剂治疗由IRAK激酶介导或相关的疾病或病症的方法。
  • Methods, compositions, and uses of novel Fyn kinase inhibitors
    申请人:Lau Warren C.
    公开号:US10688093B2
    公开(公告)日:2020-06-23
    The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
    本发明提供了使用 5-3-吡啶-2-胺、6-3-咪唑并[1,2-a]吡嗪、6-3-咪唑并[1,2-b]哒嗪、N-(5-咪唑并[2,1-b][1,3,4]噻二唑-2-基)胺、4-3-1H-吡唑并[3、4-b]吡啶和 N-(3-咪唑并[1,2-b]哒嗪-6-基)胺化合物,以及使用此类化合物治疗、预防、抑制或改善与 Fyn 激酶相关的疾病和病症的方法。
  • IRAK MODULATORS FOR TREATING AN INFLAMMATORY CONDITION, CELL PROLIFERATIVE DISORDER, IMMUNE DISORDER
    申请人:Biogen Idec MA Inc.
    公开号:EP2063962A2
    公开(公告)日:2009-06-03
  • Methods, Compositions, and Uses of Novel FYN Kinase Inhibitors
    申请人:LAU Warren C.
    公开号:US20180250297A1
    公开(公告)日:2018-09-06
    The present invention provides methods for inhibiting Fyn kinase, using 5-3-pyridin-2-amine, 6-3-imidazo[1,2-a] pyrazine, 6-3-imidazo[1,2-b] pyridazine, N-(5-imidazo [2,1-b][1,3,4] thiadiazol-2-yl)-amine, 4-3-1H-pyrazolo[3,4-b] pyridine, and N-(3-imidazo [1,2-b] pyridazin-6-yl) amine compounds and methods of treatment, prevention, inhibition or amelioration of diseases and conditions associated with Fyn kinase using such compounds.
  • [EN] DIAZOLODIAZINE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE DIAZOLODIAZINE COMME INHIBITEURS DE KINASE
    申请人:CELLZOME UK LTD
    公开号:WO2008025822A1
    公开(公告)日:2008-03-06
    [EN] The invention relates to compounds of formula (I) wherein A1, A2, X and R1 to R5 have the meaning as cited in the description and the claims. Said compounds are useful as Itk protein kinase inhibitors for the treatment or prophylaxis o f immunological, inflammatory or allergic disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the production of and use as medicaments.
    [FR] L'invention concerne des composés de formule (I) dans laquelle A1, A2, X et R1 à R5 sont tels que définis dans le descriptif et les revendications. Lesdits composés sont utilisés comme inhibiteurs de la protéine kinase Itk pour le traitement ou la prophylaxie de troubles immunologiques, inflammatoires ou allergiques. L'invention concerne également des compositions pharmaceutiques renfermant ces composés, la préparation de ces composés ainsi que leur production et leur utilisation en tant que médicaments.
查看更多